APTABIO THERAPEUTICS
AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.
APTABIO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2009-01-01
Address:
Giheung, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.aptabio.com
Total Employee:
11+
Status:
Active
Contact:
+82 31-365-3693
Total Funding:
31.8 B KRW
Technology used in webpage:
IPhone / Mobile Compatible Euro Content Delivery Network Mobile Non Scaleable Content ReCAPTCHA Pound Sterling ReCAPTCHA V2 Japanese Yen UNPKG ReCAPTCHA V3
Similar Organizations
AION Labs
AION Labs creates AI and computational technologies that transforms drug discovery.
AL Biotech
AL Biotech is a biotechnology company that develops biopharmaceutical drugs.
Amtix Bio
Amtix Bio is a biotechnology company that develops drugs to treat microbial infectious diseases and related diseases.
AULBIO
AULBIO is a research-intensive biotechnology company that develops and commercialization of biopharmaceutical products.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Jixing Pharmaceuticals
Jixing Pharmaceuticals develops innovative science and medicines to underserved Chinese patients with serious and life-threatening diseases.
Investors List
Samsung Securities
Samsung Securities investment in Series B - AptaBio Therapeutics
Midas Doang-A Investment
Midas Doang-A Investment investment in Series B - AptaBio Therapeutics
IBK Capital
IBK Capital investment in Series B - AptaBio Therapeutics
Synergy IB Investment
Synergy IB Investment investment in Series B - AptaBio Therapeutics
Shinhan Investment
Shinhan Investment investment in Series B - AptaBio Therapeutics
GMB Investment
GMB Investment investment in Series B - AptaBio Therapeutics
LB Investment
LB Investment investment in Series B - AptaBio Therapeutics
Kolon Investment
Kolon Investment investment in Series A - AptaBio Therapeutics
HB Investment
HB Investment investment in Venture Round - AptaBio Therapeutics
Official Site Inspections
http://www.aptabio.com Semrush global rank: 5.52 M Semrush visits lastest month: 1.32 K
- Host name: 112.175.85.237
- IP address: 112.175.85.237
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "AptaBio Therapeutics"
AptaBio
Aptabio is a Korean biopharmaceutical company established in 2009. Since then, Aptabio has thrived by being a pioneer and an innovator in the biopharmaceutical industry, developing âŚSee details»
AptaBio Therapeutics - Crunchbase Company Profile
AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.See details»
AptaBio Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore AptaBio Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 3 news, and 17 literature, Disease Domain:Neoplasms ...See details»
AptaBio Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 See insights on AptaBio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
AptaBio - Products, Competitors, Financials, Employees, âŚ
AptaBio is a biopharmaceutical company focused on developing immune-oncology treatments. The company's main products are designed to target and modulate the immune system to âŚSee details»
Aptabio Therapeutics Inc. Company Profile - Dun & Bradstreet
Web site created using create-react-appHome / Business Directory / Professional, Scientific, And Technical Services / Scientific Research And Development Services / Republic Of Korea / âŚSee details»
Aptabio Therapeutics - Overview, News & Similar companies
Nov 3, 2022 Aptabio Therapeutics News & Media Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022 Aptabio's âŚSee details»
Aptabio 2025 Company Profile: Stock Performance
Information on stock, financials, earnings, subsidiaries, investors, and executives for Aptabio. Use the PitchBook Platform to explore the full profile.See details»
Aptabio Therapeutics - VentureRadar
"Aptabio Therapeutics, Inc. focuses on research and development of diabetic complications and intractable cancer drugs. We are developing drugs for major indications based on the NOX âŚSee details»
AptaBio Therapeutics Inc.: Shareholders Board Members Managers âŚ
Jul 23, 2009 Aptabio Therapeutics Inc. is a Korea-based company that researches and develops new drugs. The Company is developing anti-cancer drugs, drugs for inflammatory and fibrotic âŚSee details»
Aptabio Therapeutics Inc. - BIO International Convention 2025
AptaBio Therapeutics Inc. is at the forefront of drug discovery, focusing on the development of innovative therapies through its proprietary platforms: Apta-DC (Aptamer Drug Conjugates) âŚSee details»
AptaBio Therapeutics Inc - Company Profile and News
Jul 24, 2009 Company profile page for AptaBio Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
AptaBio
íëŤíź 기ě ę¸°ë° First-in-Class ě ě˝ę°ë° ě 돸 기ě Make Life Better ěíë°ě´ě¤ë ę¸ëĄë˛ ěěĽěě 경ěë Ľ ěë ë¤ěí íě´íëźě¸ě ě§ěě ěźëĄ ę°ë°íěŹ ę¸ëĄë˛ 기ě ěźëĄ ěąěĽí´ ëę°ę˛ ěľëë¤.See details»
AptaBio Therapeutics (KOSDAQ:293780) Company Profile
Apr 14, 2025 Company profile for AptaBio Therapeutics Inc. (KOSDAQ:293780) with a description, list of executives, contact details and other key facts.See details»
Aptabio DMF, CEP, Written Confirmations, FDF, Prices, Patents, âŚ
AptaBio Co., Ltd. was established in 2009 as a biopharmaceutical company that develops platform based innovative first-in-class innovative drugs for intractable diseases. In the âŚSee details»
AptaBio
Jul 10, 2025 íëŤíź 기ě ę¸°ë° First-in-Class ě ě˝ ę°ë° ě 돸 기ě ěíë°ě´ě¤See details»
AptaBio Therapeutics - Financial Details - Crunchbase
AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.See details»
AptaBio
íëŤíź 기ě ę¸°ë° First-in-Class ě ě˝ę°ë° ě 돸 기ě ěíë°ě´ě¤ë ë ě°˝ě ě¸ íëŤíź 기ě ě ë°íěźëĄ ëěšěą ě§íě ëí First-in-Class íě ě ě˝ě ę°ë°íë ě ě˝ë°ě´ě¤ 기ě ěźëĄ 2009ë ě âŚSee details»
AptaBio Therapeutics - Profiles & Contacts - Crunchbase
AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.See details»
AptaBio
Lipofector-EXT reagents are packaged with Lipofector-Q Reagent and Plusfector Reagent. Lipofector-Q reagent is designed for the transfection of DNA or RNA into eukaryotic cells. âŚSee details»